This compound is a protected derivative of D-threonine, featuring a fluorenylmethoxycarbonyl (Fmoc) group and a tert-butyl ether protecting group. It is commonly used as a building block in solid-phase peptide synthesis, enabling the incorporation of D-threonine residues with protected side chains.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 138797-71-4
(2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methoxybutanoic acid
Peptide building block
(2R)-2-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}-4-METHYLPENTANOIC ACID
Peptide synthesis building block
9-fluorenylmethyloxycarbonyl-D-Ser(t-butyl)-OH
Peptide synthesis building block
(2R,3R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-hydroxy-4-phenylbutanoic acid
Peptide synthesis building block
Fmoc-Cys(pMeOBzl)-OH
Peptide synthesis building block
2-cyclopropyl-2-oxoacetic acid
Pharmaceutical intermediate
O,N-didesmethyltramadol
tramadol metabolite
(Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid
pharmaceutical intermediate for drug synthesis
(2R,3S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[(2-methylpropan-2-yl)oxy]butanoic acid
LZOLWEQBVPVDPR-VBKZILBWSA-N
C[C@@H]([C@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)OC(C)(C)C